首页> 美国卫生研究院文献>Cell Regulation >The Tumor Suppressor p53 Can Both Stimulate and Inhibit Ultraviolet Light–induced Apoptosis
【2h】

The Tumor Suppressor p53 Can Both Stimulate and Inhibit Ultraviolet Light–induced Apoptosis

机译:肿瘤抑制因子p53既可以刺激又可以抑制 紫外线诱导的细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We have previously shown that the tumor suppressor p53 can play a protective role against UV-induced apoptosis in human fibroblasts. In the present study, we investigated whether the protective function of p53 expression is established before or after UV irradiation. Using a stable human cell line expressing a murine temperature-sensitive p53 in which p53 function could be tightly and reversibly regulated, we found that functional p53 stimulated the induction of apoptosis when expressed for as little as 4–12 h after UV irradiation and that this induction was not dependent on de novo protein synthesis. In contrast, expression of p53 for 12 h or more before UV irradiation reduced the extent of apoptosis even when functional p53 expression was maintained after irradiation. The protection conferred by p53 required ongoing protein synthesis and correlated with enhanced recovery of mRNA synthesis. Together, these results suggest that p53 induces distinct proapoptotic and antiapoptotic signals and that these opposing activities can be separated both temporally and by their requirement for de novo protein synthesis. These findings may have important implications for the refinement of gene therapy approaches combining p53 with pharmacological agents that target transcription or translation.
机译:先前我们已经表明,肿瘤抑制因子p53可以对人成纤维细胞中UV诱导的细胞凋亡起到保护作用。在本研究中,我们调查了p53表达的保护功能是否在紫外线照射之前或之后建立。使用表达鼠温敏性p53的稳定人类细胞系,其中p53的功能可以受到严格和可逆的调节,我们发现,功能性p53在紫外线照射后短至4-12 h时能刺激细胞凋亡的诱导。诱导不依赖于从头蛋白质合成。相反,即使在辐照后维持功能性p53表达,紫外线照射前p53的表达持续12 h或更长时间仍能降低细胞凋亡的程度。 p53赋予的保护作用需要持续的蛋白质合成,并与mRNA合成的增强回收率相关。在一起,这些结果表明,p53诱导不同的促凋亡和抗凋亡信号,并且这些相反的活性可以在时间上和通过其对新生蛋白的需求而分开 合成。这些发现可能对 p53与p53结合的基因治疗方法的完善 靶向转录或翻译的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号